Matt is a Clinical-Epidemiologic Investigator at MHRP where he contributes to the scientific oversight and direction of epidemiologic studies in HIV, sexually transmitted infections, and other infectious diseases. He is an associate investigator for the African Cohort Study (AFRICOS) in Kenya, Nigeria, Tanzania, and Uganda and the Multinational Observational Cohort of HIV and other Infections (MOCHI) in Kenya, Uganda, and The Philippines.
Matt is a registered pharmacist and doctoral-trained epidemiologist with a research focus on using implementation science and disease surveillance methods to improve population health and promote health equity. He completed his PhD in epidemiology under the mentorship of Professor Denis Nash (Graduate School of Public Health and Health Policy, City University of New York) and did his dissertation in collaboration with the International epidemiology Databases to Evaluate AIDS (IeDEA) research consortium. Matt has worked extensively with Latin American investigators on research related to neurocysticercosis diagnosis and treatment and with the New York City Health Department on surveillance and equity initiatives. Matt is also passionate about training and mentorship in epidemiology and public health and has previously held teaching positions at The University of Hong Kong and City University of New York.
Romo ML, Osorio R, Toledo A, Carrillo-Mezo R, Valdez R, Romano MC, Sciutto E, Fragoso G, Fleury A. Low responsiveness of peripheral lymphocytes in extraparenchymal neurocysticercosis. PLOS Neglected Tropical Diseases. 2023;7(6):e0011386.
Romo ML, Brazier E, Mahambou-Nsondé D, De Waal R, Sekaggya-Wiltshire C, Chimbete C, Muyindike WR, Murenzi G, Kunzekwenyika C, Tiendrebeogo, T, Muhairwe JA, Lelo P, Dzudie A, Twizere C, Rafael I, Ezechi OC, Diero L, Yotebieng M, Fenner L, Wools-Kaloustian KK, Shah NS, Nash D; on behalf of the International epidemiology Databases to Evaluate AIDS (IeDEA). Real-world use and outcomes of dolutegravir-containing antiretroviral therapy in HIV and tuberculosis co-infection: A site survey and cohort study in sub-Saharan Africa. Journal of the International AIDS Society. 2022;25:e25961.
Romo ML, Edwards JK, Semeere AS, Musick BS, Urassa M, Odhiambo F, Diero L, Kasozi C, Murenzi G, Lelo P, Wyka K, Kelvin EA, Sohn AH, Wools-Kaloustian KK, Nash D; on behalf of the International epidemiology Databases to Evaluate AIDS (IeDEA). Viral load status before switching to dolutegravir-containing antiretroviral therapy and associations with HIV treatment outcomes in sub-Saharan Africa. Clinical Infectious Diseases. 2022;75(4):630-637.
Romo ML, Patel RC, Edwards JK, Humphrey JM, Musick BS, Bernard C, Maina MW, Brazier E, Castelnuovo B, Penner J, Wyka K, Wagner Cardoso S, Ly PS, Kunzekwenyika C, Cortés CP, Panczak R, Kelvin EA, Wools-Kaloustian KK, Nash D; on behalf of the International epidemiology Databases to Evaluate AIDS (IeDEA). Disparities in dolutegravir uptake among females of reproductive age with HIV in low- and middle-income countries following initial concerns about teratogenicity. An observational study. Annals of Internal Medicine. 2022;175(1):84-94.
Romo ML, Hernández M, Astudillo OG, Diego G, de la Rosa Arana JL, Meza-Lucas A, García-Rodea R, Toledo A, Parkhouse RME, Garate T, Sciutto E, Fleury A. Diagnostic value of glycoprotein band patterns of three serologic enzyme-linked immunoelectrotransfer blot assays for neurocysticercosis. Parasitology Research. 2020;119(8):2521-2529.
Romo ML, Bojórquez-Chapela I. Características de la migración de retorno a México por motivos de salud, 2014-2016 [Characteristics of migrants who return to Mexico for health reasons, 2014-2016]. Salud Pública de México. 2018;69:489-491.
Romo ML, George G, Mantell JE, Mwai E, Nyaga E, Odhiambo JO, Govender K, Kelvin EA. Psychosocial characteristics of primary care-seeking long-distance truck drivers in Kenya and associations with HIV testing. African Journal of AIDS Research. 2018;17:119-128.
Romo ML, Carpio A, Parkhouse RME, Cortez MM, Rodriguez-Hidalgo R. Comparison of complementary diagnostic tests in cerebrospinal fluid and serum for neurocysticercosis. Heliyon. 2018;4:e00991.
Romo ML, Chan PY, Lurie-Moroni E, Perlman SE, Newton-Dame R, Thorpe LE, et al. Characterizing adults receiving primary medical care in New York City: Implications for using electronic health records for chronic disease surveillance. Preventing Chronic Disease. 2016;13:E56.
Romo ML, Wyka K, Carpio A, Leslie D, Andrews H, Bagiella E, Hauser WA, Kelvin EA; for the Ecuadorian Neurocysticercosis Group. Effect of albendazole treatment on seizure outcomes in patients with symptomatic neurocysticercosis. Transactions of the Royal Society of Tropical Medicine and Hygiene. 2015;109:738-746.
Full list of publications: https://www.ncbi.nlm.nih.gov/myncbi/matthew.romo.2/bibliography/public/